ClinicalTrials HQ

Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA)

Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA)

Active, not recruiting · NCT07146022 · Registry updated 2026-08-17
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA)Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, alopecia, androgenetic alopecia, disorder of pilosebaceous unit, hypotrichosis, skin disorderActive, not recruitingPhase 32026-08-17NCT07146022

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Veradermics, Inc.4

71 results · Page 1 of 3

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Site 11ColumbusUnited States2
Site 12MetairieUnited States2
Site 13CovingtonUnited States2
Site 14HoustonUnited States2
Site 15IndianapolisUnited States2
Site 17AventuraUnited States2
Site 18HackensackUnited States2
Site 19South JordanUnited States1
Site 2FremontUnited States1
Site 21VistaUnited States2
Site 22BrightonUnited States2
Site 24Greenwood VillageUnited States1
Site 26ClarkstonUnited States2
Site 27West LafayetteUnited States2
Site 29ForestUnited States1
Site 30Fort SmithUnited States2
Site 31BoiseUnited States2
Site 32New AlbanyUnited States2
Site 33BurienUnited States1
Site 34Sherman OaksUnited States2
Site 37Kew GardensUnited States2
Site 39BoardmanUnited States2
Site 4NashvilleUnited States1
Site 41Baton RougeUnited States2
Site 43AtlantaUnited States2